HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Privigen

10% liquid formulation of intravenous immunoglobulin, stabilized with 250 mmol/L L-proline for treatment of patients with primary immunodeficiency disease
Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Robberecht, Wim: 1 article (06/2013)
2. Zenker, Othmar: 1 article (06/2013)
3. Bauhofer, Artur: 1 article (06/2013)
4. Tackenberg, Björn: 1 article (06/2013)
5. Stelmasiak, Zbigniew: 1 article (06/2013)
6. Mielke, Orell: 1 article (06/2013)
7. PRIMA study investigators: 1 article (06/2013)
8. Kamienowski, Jerzy: 1 article (06/2013)
9. De Bleecker, Jan L: 1 article (06/2013)
10. Léger, Jean-Marc: 1 article (06/2013)

Related Diseases

1. Hemorrhage
2. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
3. Polyneuropathies (Polyneuropathy)
4. Common Variable Immunodeficiency
5. Thrombocytopenic Purpura (Thrombopenic Purpura)

Related Drugs and Biologics

1. Inosine Triphosphate (ITP)
2. Immunoglobulins (Immunoglobulin)
3. Intravenous Immunoglobulins (IVIG)
4. Proline (L-Proline)
5. Bruton type agammaglobulinemia